Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis.
作者信息
Karagiannidis Christian, Sander Leif-Erik, Mall Marcus A, Busse Reinhard
机构信息
Department of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Center, Kliniken Der Stadt Köln, Witten/Herdecke University Hospital, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Department of Infectious Diseases and Respiratory Medicine, Charité-Universitaetsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu, Berlin, Germany.
出版信息
Infection. 2022 Dec;50(6):1627-1629. doi: 10.1007/s15010-022-01877-w. Epub 2022 Jun 30.
Abstract
摘要
相似文献
1
Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis.德国新冠病毒相关儿童多系统炎症综合征的发病率及转归：一项全国性分析
Infection. 2022 Dec;50(6):1627-1629. doi: 10.1007/s15010-022-01877-w. Epub 2022 Jun 30.
2
Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.德国儿童 SARS-CoV-2 感染患者发生 COVID-19 和 PIMS-TS 严重结局的风险。
Eur J Pediatr. 2022 Oct;181(10):3635-3643. doi: 10.1007/s00431-022-04587-5. Epub 2022 Aug 13.
3
Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic.捷克共和国一项与 SARS-CoV-2 相关的儿童炎症性多系统综合征的全国性观察性研究（PIMS-TS）。
Eur J Pediatr. 2022 Oct;181(10):3663-3672. doi: 10.1007/s00431-022-04593-7. Epub 2022 Aug 20.
4
Monitoring the spatiotemporal epidemiology of Covid-19 incidence and mortality: A small-area analysis in Germany.监测新冠发病率和死亡率的时空流行病学：德国小区域分析。
Spat Spatiotemporal Epidemiol. 2021 Aug;38:100433. doi: 10.1016/j.sste.2021.100433. Epub 2021 May 21.
5
Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany.德国：针对 SARS-CoV-2 的抗体表明有单次溢出到牛的事件。
Emerg Infect Dis. 2022 Sep;28(9):1916-1918. doi: 10.3201/eid2809.220125. Epub 2022 Aug 1.
6
Air quality in Germany as a contributing factor to morbidity from COVID-19.德国的空气质量是导致 COVID-19 发病的一个因素。
Environ Res. 2022 Nov;214(Pt 2):113896. doi: 10.1016/j.envres.2022.113896. Epub 2022 Jul 13.
7
Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.2020 年德国东部第一波和第二波新冠疫情期间 SARS-CoV-2 谱系发展的系统进化分析：第二波疫情成因的启示。
Epidemiol Infect. 2021 Jul 30;149:e177. doi: 10.1017/S0950268821001461.
8
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益（CoV-Surv 研究）：一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
9
COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.COVID-19：热点医院？-德国二级保健医院网络中医院员工的 SARS-CoV-2 抗体血清阳性率：一项前瞻性监测研究的中期结果。
Int J Hyg Environ Health. 2021 Jun;235:113771. doi: 10.1016/j.ijheh.2021.113771. Epub 2021 May 20.
10
Utilization Of Cardiac Rehabilitation During the SARS-CoV-2 Pandemic In Germany: A Difference-In-differences Analysis.德国新冠疫情期间心脏康复的利用情况：一项双重差分分析
J Cardiopulm Rehabil Prev. 2022 Jul 1;42(4):287-289. doi: 10.1097/HCR.0000000000000704.
引用本文的文献
1
Cytokine landscape in hospitalized children with multisystem inflammatory syndrome.住院儿童多系统炎症综合征的细胞因子特征。
Sci Rep. 2024 Oct 1;14(1):22803. doi: 10.1038/s41598-024-73956-x.
2
In-hospital unfavorable outcomes of MIS-C during 2020-2022: a systematic review.2020-2022 年 MIS-C 住院期间不良结局的系统评价。
Eur J Pediatr. 2024 Dec;183(12):5071-5084. doi: 10.1007/s00431-024-05787-x. Epub 2024 Oct 1.
3
Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study.儿童多系统炎症综合征与 BNT162b2 疫苗：一项全国性队列研究。
Eur J Pediatr. 2024 Aug;183(8):3319-3326. doi: 10.1007/s00431-024-05586-4. Epub 2024 May 9.
4
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.儿童多系统炎症综合征（MIS-C）：希腊人群的全国性合作研究。
Eur J Pediatr. 2024 Apr;183(4):1693-1702. doi: 10.1007/s00431-023-05383-5. Epub 2024 Jan 12.
5
Clinical characteristics of COVID-19 associated vasculopathic diseases.新型冠状病毒肺炎相关血管病变疾病的临床特征
Thromb J. 2023 May 25;21(1):61. doi: 10.1186/s12959-023-00504-4.
6
Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg.卢森堡新冠疫情头两年期间儿童多系统炎症综合征
Front Pediatr. 2023 Apr 5;11:1141074. doi: 10.3389/fped.2023.1141074. eCollection 2023.
7
Administrative data in pediatric critical care research-Potential, challenges, and future directions.儿科重症监护研究中的行政数据——潜力、挑战及未来方向。
Front Pediatr. 2022 Sep 28;10:1014094. doi: 10.3389/fped.2022.1014094. eCollection 2022.
本文引用的文献
1
Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.法国青少年 COVID-19 疫苗接种状况与儿童多系统炎症综合征的关系。
JAMA. 2022 Jan 18;327(3):281-283. doi: 10.1001/jama.2021.23262.
2
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.儿童多系统炎症综合征 - 初始治疗和结局。
N Engl J Med. 2021 Jul 1;385(1):23-34. doi: 10.1056/NEJMoa2102605. Epub 2021 Jun 16.
3
COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis.儿童新冠病毒感染与多系统炎症综合征：一项系统综述与荟萃分析。
Pediatr Pulmonol. 2021 May;56(5):837-848. doi: 10.1002/ppul.25245. Epub 2021 Jan 11.
4
Kawasaki Disease in Germany: A Prospective, Population-based Study Adjusted for Underreporting.德国川崎病：一项针对漏报情况进行调整的基于人群的前瞻性研究。
Pediatr Infect Dis J. 2016 Feb;35(2):129-34. doi: 10.1097/INF.0000000000000953.
Zotero 插件